- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Devyser Diagnostics AB (DVYSR)
Devyser Diagnostics AB stock price live, this page displays ST DVYSR stock exchange data. View the DVYSR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Devyser Diagnostics AB real time stock price chart below.
What Is the Devyser Diagnostics AB Stock Price Today?
The Devyser Diagnostics AB stock price today is 63.00.
What Is the Stock Symbol for Devyser Diagnostics AB?
The stock symbol for Devyser Diagnostics AB is "DVYSR."
What Stock Exchange Does Devyser Diagnostics AB Trade On?
Devyser Diagnostics AB is listed and trades on the Stockholm stock exchange.
Is Devyser Diagnostics AB a Good Stock to Buy?
Determining whether Devyser Diagnostics AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DVYSR quote. (ISIN: SE0016588867)
What Is the Devyser Diagnostics AB Stock Price Today?
The Devyser Diagnostics AB stock price today is 63.00.
What Is the Stock Symbol for Devyser Diagnostics AB?
The stock symbol for Devyser Diagnostics AB is "DVYSR."
What Stock Exchange Does Devyser Diagnostics AB Trade On?
Devyser Diagnostics AB is listed and trades on the Stockholm stock exchange.
Is Devyser Diagnostics AB a Good Stock to Buy?
Determining whether Devyser Diagnostics AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DVYSR quote. (ISIN: SE0016588867)
Stockholm
Currency in SEK
63.00
0.00(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
59.80
67.20
52 wk Range
57.80
159.60
DVYSR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
59.8067.20
52 wk Range
57.80159.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DVYSR Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
138.58
Upside
+119.97%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 138.58
(+119.97% Upside)
Devyser Diagnostics AB Earnings Call Summary for Q2/2026
- Q2 revenue fell 11% to 60M SEK vs 67M SEK prior year, missing analyst estimates of 77.9M SEK due to weak distributor orders from Thermo Fisher.
- Posted fifth consecutive quarter of positive EBIT at 0.5M SEK; gross margin of 76% impacted by one-time inventory adjustment, normalized at 80%.
- Company ended quarter with 81M SEK cash and secured 70M SEK credit facility from SEB; operating cash flow reached 12.3M SEK in the quarter.
- Management expects transplant segment weakness through H2 2026 with recovery in 2027; hereditary products showed strong growth, up 14% year-over-year.
- Launched Chimerism Plus product to strengthen competitive position; current 30% growth target expires end-2026, new guidance to be provided later.
Last Updated: 2026-07-20, 03:36 a/m
Read Full TranscriptEarnings
Latest Release
Jul 20, 2026
EPS / Forecast
-- / 0.68
Revenue / Forecast
-- / 77.9M
Compare DVYSR to Peers and Sector
Metrics to compare | DVYSR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDVYSRPeersSector | |
|---|---|---|---|---|
P/E Ratio | 70.5x | −5.2x | −0.4x | |
PEG Ratio | 0.58 | −0.07 | 0.00 | |
Price/Book | 3.0x | 2.4x | 2.6x | |
Price / LTM Sales | 4.1x | 10.7x | 3.0x | |
Upside (Analyst Target) | 67.1% | 67.2% | 54.6% | |
Fair Value Upside | Unlock | −7.4% | 9.7% | Unlock |
Devyser Diagnostics AB (publ) provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa. It offers kits and reagents, such as post-transplantation, thalassemia, fetal RHD screening NIPT, Cystic fibrosis cardiovascular diseases, male infertility, rapid aneuploidy analysis, accessories, hereditary cancer, and transfusion medicine products; and Amplicon Suite and Advyser for cloud-based software solutions for data analysis and the interpretation of test results. The company was incorporated in 2004 and is headquartered in Årsta, Sweden.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Devyser Diagnostics AB (DVYSR) Stock Price Today?
The Devyser Diagnostics AB stock price today is 63.00 SEK.
What Stock Exchange Does Devyser Diagnostics AB Trade On?
Devyser Diagnostics AB is listed and trades on the Stockholm Stock Exchange.
What Is the Stock Symbol for Devyser Diagnostics AB?
The stock symbol for Devyser Diagnostics AB is "DVYSR."
What Is the Devyser Diagnostics AB Market Cap?
As of today, Devyser Diagnostics AB market cap is 1.06B SEK.
What Is Devyser Diagnostics AB's Earnings Per Share (TTM)?
The Devyser Diagnostics AB EPS (TTM) is 0.89.
When Is the Next Devyser Diagnostics AB Earnings Date?
Devyser Diagnostics AB will release its next earnings report on Nov 03, 2026.
From a Technical Analysis Perspective, Is DVYSR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Devyser Diagnostics AB Stock Split?
Devyser Diagnostics AB has split 0 times.
How Many Employees Does Devyser Diagnostics AB Have?
Devyser Diagnostics AB has 110 employees.
What is the current trading status of Devyser Diagnostics AB (DVYSR)?
As of Jul 21, 2026, Devyser Diagnostics AB (DVYSR) is trading at a price of 63.00 SEK, with a previous close of 63.00 SEK. The stock has fluctuated within a day range of 59.80 SEK to 67.20 SEK, while its 52-week range spans from 57.80 SEK to 159.60 SEK.
What Is Devyser Diagnostics AB (DVYSR) Price Target According to Analysts?
The average 12-month price target for Devyser Diagnostics AB is 138.58 SEK, with a high estimate of 167.55319149 SEK and a low estimate of 105.15514184 SEK. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +119.97% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.